CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE5437.45-8.9 (-0.16 %)
PREV CLOSE () 5446.35
OPEN PRICE () 5436.65
BID PRICE (QTY) 5429.25 (4)
OFFER PRICE (QTY) 5446.30 (2)
VOLUME 10
TODAY'S LOW / HIGH ()5429.25 5437.45
52 WK LOW / HIGH ()4640.3 5835.95
NSE5435.20-13.95 (-0.26 %)
PREV CLOSE() 5449.15
OPEN PRICE () 5450.00
BID PRICE (QTY) 5435.20 (1)
OFFER PRICE (QTY) 5439.75 (1)
VOLUME 234
TODAY'S LOW / HIGH() 5423.00 5460.40
52 WK LOW / HIGH ()4636.55 5850
ChairmanSuresh N Talwar
Managing DirectorMilind Thatte
Company SecretaryZeal Rupani
Executive DirectorLokesh Chandak
Non Executive DirectorAalok Agrawal
Seema Sambasivan
Non Executive Independent DirectorRani Jadhav Ajit
S Madhavan
Incorporation Year : 26-04 1967

Registered Office :

Address : Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East) Mumbai,
Maharashtra-400099 .

Phone : 022 68669000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX78980.12507.64 (0.65%)
NIFTY23927.60177.40 (0.75%)
Dow Jones 43325.8028.77 (0.07%)
Nasdaq 20020.36-10.77 (-0.05%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI